ClinicalTrials.Veeva

Menu

Smoking Cessation for Patients With Acute Coronary Syndrome (ACS) (PATPAC)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Acute Coronary Syndrome
Smoking

Treatments

Behavioral: conventional follow-up
Behavioral: Technique of in-vivo exposure (cigarette) and mental image exposure (craving)

Study type

Interventional

Funder types

Other

Identifiers

NCT00987597
ID RCB : 2008-A00509-46
EUDRACT : 2008-00267712
LRB0801

Details and patient eligibility

About

The aim of the present study is to assess if a personal care program of smokers hospitalised for acute coronary syndrome can change the smoking habits as compared with similar patients in conventional care program at 6 months. The program includes a cognitive-behavioural approach associated with a nicotine replacement treatment presented as an obligatory non optional treatment. Patients are men and women of less than 70 years old hospitalised for acute coronary syndrome. Major exclusion criteria is the presence of another dependence. The program includes a cognitive-behavioural approach based on the specific technique of "exposure" and the prescription of nicotine patch considered as other usual cardiologic treatments for at least 6 months. The end point is the smoking habits at 6 months classified as: no smoking confirmed by CO measurement, smoking or doubtful (declaration of no smoking by the patient but a CO level > 10 ppm). 72 patients in each group will be included in 2 majors sites.

Full description

The cognitive behavioural approach group : This group will receive an inclusion visit at first, then two "cigaret exposures cessions" during hospitalisation. Thereafter-one week after he's out- the patient will come for 5 follow up visits consisting in the specific technique of cigaret exposure and nicotinic treatment adjustment. Then the last visit, at six months, will tell us if the patient is an effective non smoker or not; We'll be also collecting psychological and medical informations (such as the treatment, IMC, cardiovascular check up and psychological tests). The control group : This group is managed as "usual" : the nurse gives very rapid recommendations to the patients concerning smoking cessation. Nicotinic substitutes are proposed to the patients but the patient must find them by itself.

Enrollment

144 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients are men and women of less than 70 years old
  • Hospitalised for acute coronary syndrome in cardiology Intensive Care Unit
  • Active smoking >5 cigarettes/day
  • Has given consent to participate in the study and haven't expressed its opposition the exploitation of data as part of the study

Exclusion criteria

  • Presence of another dependence : alcohol abuse avowed or strongly suspected, addiction to drugs, high dose benzodiazepine dependence. clinical assessment
  • Major psychiatric disorders or history. clinical assessment
  • Treatment with lithium and neuroleptic. clinical assessment
  • Patient whose cardiac problem could lead to hemodynamic instability during 48 h after admission.
  • Patient scheduled for programmed hospitalisation within 6 months after release from hospital (>3 days long, including coronary bypass)
  • Patients presenting another severe pathology requiring 6 months specific treatments. clinical assessment
  • Patient which cannot understand or read French
  • Patient with possible side-effect to nicotine substitute
  • Patient unaffiliated to any social security regime

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

144 participants in 2 patient groups

cognitive behavioural approach
Experimental group
Description:
specific technique of cigarette exposure and nicotinic treatment adjustment
Treatment:
Behavioral: Technique of in-vivo exposure (cigarette) and mental image exposure (craving)
usual approach
Active Comparator group
Description:
recommendations and nicotinic substitutes
Treatment:
Behavioral: conventional follow-up

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems